Tansna Therapeutics
About:
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy.
Website: http://www.tansna.com
Top Investors: BioGenerator, iSelect Fund
Description:
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy. The company was founded in 2010.
Total Funding Amount:
$850000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
St Louis, Missouri, United States
Founded Date:
2010-01-01
Founders:
Max Baker
Number of Employees:
1-10
Last Funding Date:
2014-02-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai